Skip to main content
. 2016 Jun 16;1(9):e87607. doi: 10.1172/jci.insight.87607

Figure 1. PRL-3 is an oncotarget highly expressed in tumor tissues.

Figure 1

(A) Western blots of PRL-3 in various normal tissues of FVB/wild-type mice (lanes 1–15) and spontaneous breast and metastatic lung tumors from FVB/MMTV-PyMT mice (lanes 16 and 17). HSP60, loading control. (B) Kaplan-Meier survival analysis of PRL-3 mRNA expression in the Singapore (SGSet1) gastric cancer (GC) patient cohort. n = 183; P = 0.002, log-rank test. (C) Full Western blot analysis of PRL-3 in 20 pairs of human primary gastric tumors (T) versus patient-matched normal stomach tissues (n) from 20 random GC patients. GAPDH, loading control; Mr, relative molecular mass (kDa).